Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Impaired Lysophosphatidic Acid Receptor 3 Signaling in Mesenchymal Stromal Cells Promotes Multiple Myeloma Progression through Cellular Senescence and Transdifferentiation into Tumor-Associated Fibroblasts

Masahiko Kanehira, DVM, PhD, Tohru Fujiwara, MD PhD, Shinji Nakajima, MD PhD, Yoko Okitsu, MD PhD, Yasushi Ohnishi, MD PhD, Noriko Fukuhara, MD PhD, Ryo Ichinohasama, MD PhD, Hideo Harigae, MD PhD

Blood (2015) 126 (23): 1764.

https://doi.org/10.1182/blood.V126.23.1764.1764

Published: 2015

Journal Articles

Exploring the Potential Usefulness of 5-Aminolevulinic Acid for X-Linked Sideroblastic Anemia

Tohru Fujiwara, MD PhD, Ryoyu Niikuni, Koji Okamoto, Yoko Okitsu, MD PhD, Noriko Fukuhara, MD PhD, Yasushi Onishi, MD PhD, Kenichi Ishizawa, MD PhD, Ryo Ichinohasama, MD PhD, Yukio Nakamura, MD, PhD, Tohru Tanaka, PhD, Hideo Harigae, MD PhD

Blood (2014) 124 (21): 215.

https://doi.org/10.1182/blood.V124.21.215.215

Published: 2014

Journal Articles

A Low-Molecular-Weight Compound K7174 Represses Hepcidin: Possible Therapeutic Strategy Against Anemia Of Chronic Disease

Tohru Fujiwara, MD, PhD, Takashi Ikeda, Yuki Nagasaka, Yoko Okitsu, MD, PhD, Noriko Fukuhara, MD, PhD, Yasushi Onishi, MD, PhD, Kenichi Ishizawa, MD, Ryo Ichinohasama, MD, PhD, Naohisa Tomosugi, MD, PhD, Hideo Harigae, MD, PhD

Blood (2013) 122 (21): 3436.

https://doi.org/10.1182/blood.V122.21.3436.3436

Published: 2013

Journal Articles

Regulation of Erythropoiesis by Histone Methyltransferase EZH2 Inhibitor 3-Deazaneplanocin A (DZNep)

Tohru Fujiwara, MD, PhD, Haruka Saitoh, Yoko Okitsu, MD, PhD, Noriko Fukuhara, MD, PhD, Yasushi Onishi, MD, PhD, Kenichi Ishizawa, MD, PhD, Ryo Ichinohasama, MD, PhD, Hideo Harigae, MD, PhD

Blood (2012) 120 (21): 982.

https://doi.org/10.1182/blood.V120.21.982.982

Published: 2012

Journal Articles

Clinicopathological Features of Malignant Lymphoma in JAPAN- Data From the Miyagi Study.

Yukiko Miura, M.D, Joji Yamamoto, M.D., Ph.D., Katsura Kohata, M.D., Ph.D., Kenichi Ishizawa, M.D., Ph.D, Ryo Ichinohasama, M.D., Ph.D., Hideo Harigae, M.D., Ph.D

Blood (2009) 114 (22): 4997.

https://doi.org/10.1182/blood.V114.22.4997.4997

Published: 2009

Journal Articles

Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer–cell lymphoma/leukemia

Yasuo Yamanaka, Hiroyuki Tagawa, Naoto Takahashi, Atsushi Watanabe, Yong-Mei Guo, Keiko Iwamoto, Junsuke Yamashita, Hirobumi Saitoh, Yoshihiro Kameoka, Norio Shimizu, Ryo Ichinohasama, Ken-ichi Sawada

Blood (2009) 114 (15): 3265–3275.

https://doi.org/10.1182/blood-2009-06-222794

Published: 2009

Includes: Supplemental data

Journal Articles

De Novo CD5 + Diffuse Large B-Cell Lymphoma: Result of a Detail Morphologic Evaluation and Long-Term Follow Up of 128 Patients.

Motoko Yamaguchi, MD, PhD, Naoya Nakamura, MD, PhD, Ritsuro Suzuki, MD, PhD, Yoshitoyo Kagami, MD, PhD, Masataka Okamoto, MD, PhD, Ryo Ichinohasama, MD, PhD, Tadashi Yoshino, MD, PhD, Junji Suzumiya, MD, PhD, Takuhei Murase, MD, PhD, Ikuo Miura, MD, PhD, Masami Hirano, MD, PhD, Yasuo Morishima, MD, PhD, Hiroshi Shiku, MD, PhD, Ryuzo Ueda, MD, PhD, Shigeo Nakamura, MD, PhD

Blood (2007) 110 (11): 1564.

https://doi.org/10.1182/blood.V110.11.1564.1564

Published: 2007

Journal Articles

Identification of RIZ1 Targets Involvedin Erythroid Differentiation of K562 Human Erythroleukemia Cells Using Surface-Enhanced Laser Desorption Ionization Time-Of-Flight Mass Spectrometry (SELDI).

Naoto Takahashi, MD, PhD, Matthew Brainbridge, BSc, Stuart A. Scott, BSc, Ryo Ichinohasama, MD, PhD, Stephen E. Sanche, MD, Wei-Feng Dong, MD, PhD, John F. DeCoteau, MD, C. R. Geyer, PhD

Blood (2004) 104 (11): 2031.

https://doi.org/10.1182/blood.V104.11.2031.2031

Published: 2004

Journal Articles

cDNA Microarray Analysis of Genes Up-Regulated by Treatment with 5-AZA-2′-Deoxycytidine in Combination with Trichostatin A Identifies Aberrant Metallothionein 1H Promoter Methylation at a High Frequency Iin Human AML.

Stuart A. Scott, BSc, Derek S. Pearson, MD, Matthew N. Bainbridge, BSc, Wei-Feng Dong, MD, PhD, Naoto Takahashi, MD, PhD, David P. Sheridan, MD, Ryo Ichinohasama, MD, PhD, C. R. Geyer, PhD, John F. DeCoteau, MD

Blood (2004) 104 (11): 2036.

https://doi.org/10.1182/blood.V104.11.2036.2036

Published: 2004

Journal Articles

An IELSG International Survey of Primary Effusion Lymphoma (PEL).

Blood (2004) 104 (11): 3265.

https://doi.org/10.1182/blood.V104.11.3265.3265

Published: 2004

Journal Articles

De novo CD5 + diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients

Motoko Yamaguchi, Masao Seto, Masataka Okamoto, Ryo Ichinohasama, Naoya Nakamura, Tadashi Yoshino, Junji Suzumiya, Takuhei Murase, Ikuo Miura, Takashi Akasaka, Jun-ichi Tamaru, Ritsuro Suzuki, Yoshitoyo Kagami, Masami Hirano, Yasuo Morishima, Ryuzo Ueda, Hiroshi Shiku, Shigeo Nakamura

Blood (2002) 99 (3): 815–821.

https://doi.org/10.1182/blood.V99.3.815

Published: 2002

Journal Articles

Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype

Ritsuro Suzuki, Yoshitoyo Kagami, Kengo Takeuchi, Masahiro Kami, Masataka Okamoto, Ryo Ichinohasama, Naoyoshi Mori, Masaru Kojima, Tadashi Yoshino, Hirohiko Yamabe, Mami Shiota, Shigeo Mori, Michinori Ogura, Nobuyuki Hamajima, Masao Seto, Taizan Suchi, Yasuo Morishima, Shigeo Nakamura

Blood (2000) 96 (9): 2993–3000.

https://doi.org/10.1182/blood.V96.9.2993

Published: 2000

Journal Articles

The Ikaros gene, a central regulator of lymphoid differentiation, fuses to the BCL6 gene as a result of t(3;7)(q27;p12) translocation in a patient with diffuse large B-cell lymphoma

Yoshitaka Hosokawa, Yumiko Maeda, Ryo Ichinohasama, Ikuo Miura, Masafumi Taniwaki, Masao Seto

Blood (2000) 95 (8): 2719–2721.

https://doi.org/10.1182/blood.V95.8.2719

Published: 2000

Journal Articles

Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma

Yasushi Yatabe, Ritsuro Suzuki, Kensei Tobinai, Yoshihiro Matsuno, Ryo Ichinohasama, Masataka Okamoto, Motoko Yamaguchi, Jun-ichi Tamaru, Naokuni Uike, Yuko Hashimoto, Yasuo Morishima, Taizan Suchi, Masao Seto, Shigeo Nakamura

Blood (2000) 95 (7): 2253–2261.

https://doi.org/10.1182/blood.V95.7.2253

Published: 2000

Journal Articles

MSH2- deficient murine lymphomas harbor insertion/deletion mutations in the transforming growth factor beta receptor type 2 gene and display low not high frequency microsatellite instability

Robert Lowsky, Anthony Magliocco, Ryo Ichinohasama, Armin Reitmair, Stuart Scott, Michele Henry, Marshall E. Kadin, John F. DeCoteau

Blood (2000) 95 (5): 1767–1772.

https://doi.org/10.1182/blood.V95.5.1767.005k07_1767_1772

Published: 2000

Journal Articles

Defects of the Mismatch Repair Gene MSH2 Are Implicated in the Development of Murine and Human Lymphoblastic Lymphomas and Are Associated With the Aberrant Expression of Rhombotin-2 (Lmo-2) and Tal-1 (SCL)

Robert Lowsky, John F. DeCoteau, Armin H. Reitmair, Ryo Ichinohasama, Wei-Feng Dong, Yi Xu, Tak W. Mak, Marshall E. Kadin, Mark D. Minden

Blood (1997) 89 (7): 2276–2282.

https://doi.org/10.1182/blood.V89.7.2276

Published: 1997

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Impaired Lysophosphatidic Acid Receptor 3 Signaling in Mesenchymal Stromal Cells Promotes Multiple Myeloma Progression through Cellular Senescence and Transdifferentiation into Tumor-Associated Fibroblasts

Exploring the Potential Usefulness of 5-Aminolevulinic Acid for X-Linked Sideroblastic Anemia

A Low-Molecular-Weight Compound K7174 Represses Hepcidin: Possible Therapeutic Strategy Against Anemia Of Chronic Disease

Regulation of Erythropoiesis by Histone Methyltransferase EZH2 Inhibitor 3-Deazaneplanocin A (DZNep)

Clinicopathological Features of Malignant Lymphoma in JAPAN- Data From the Miyagi Study.

Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer–cell lymphoma/leukemia

De Novo CD5 + Diffuse Large B-Cell Lymphoma: Result of a Detail Morphologic Evaluation and Long-Term Follow Up of 128 Patients.

Identification of RIZ1 Targets Involvedin Erythroid Differentiation of K562 Human Erythroleukemia Cells Using Surface-Enhanced Laser Desorption Ionization Time-Of-Flight Mass Spectrometry (SELDI).

cDNA Microarray Analysis of Genes Up-Regulated by Treatment with 5-AZA-2′-Deoxycytidine in Combination with Trichostatin A Identifies Aberrant Metallothionein 1H Promoter Methylation at a High Frequency Iin Human AML.

An IELSG International Survey of Primary Effusion Lymphoma (PEL).

De novo CD5 + diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients

Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype

The Ikaros gene, a central regulator of lymphoid differentiation, fuses to the BCL6 gene as a result of t(3;7)(q27;p12) translocation in a patient with diffuse large B-cell lymphoma

Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma

MSH2- deficient murine lymphomas harbor insertion/deletion mutations in the transforming growth factor beta receptor type 2 gene and display low not high frequency microsatellite instability

Defects of the Mismatch Repair Gene MSH2 Are Implicated in the Development of Murine and Human Lymphoblastic Lymphomas and Are Associated With the Aberrant Expression of Rhombotin-2 (Lmo-2) and Tal-1 (SCL)

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only